# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001213900-19-026699
Filing Date
2019-12-20
Accepted
2019-12-20 16:31:07
Documents
5
Effectiveness Date
2019-12-20

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFINITIVE ADDITIONAL MATERIALS | defa14a121319_citiuspharma.htm | DEFA14A | 26316
2 | GRAPHIC | image_001.jpg | GRAPHIC | 339994
3 | GRAPHIC | image_002.jpg | GRAPHIC | 463592
4 | GRAPHIC | image_003.jpg | GRAPHIC | 200138
5 | GRAPHIC | image_004.jpg | GRAPHIC | 158158
| Complete submission text file | 0001213900-19-026699.txt |  | 1627886

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-38174 | Film No.: 191301997
SIC: 2834 Pharmaceutical Preparations